Norges Bank’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
Norges Bank's COLL Position: Q2 2026 in Review
Norges Bank sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 112,500 shares — an estimated $5.21M sold.
Norges Bank first reported a position in COLL in Q2 2015 and held it in 3 quarters. The position peaked at $5.21M in Q4 2025. 281 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- Norges Bank reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
- Norges Bank sold 112,500 Collegium Pharmaceutical shares in Q2 2026, an estimated $5.21M.
- Norges Bank first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 3 quarters.
- Norges Bank's Collegium Pharmaceutical position peaked at $5.21M in Q4 2025.
- 281 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.